gastrointestinal-and-intestinal-disorders | Media Room | PressRelease.com

Tagged gastrointestinal-and-intestinal-disorders

Mahana Therapeutics Obtains CE Mark for Parallel™ in the UK

Press Release Mar 9, 2021

Mahana Therapeutics Obtains CE Mark for Parallel™ in the UK

First Prescription Digital Therapeutic to Reduce the Symptom Severity of Irritable Bowel Syndrome Also Receives NICE Recommendation

Mahana Therapeutics Obtains FDA Marketing Authorization for the First Prescription Digital Therapeutic to Treat Irritable Bowel Syndrome

Press Release Dec 8, 2020

Mahana Therapeutics Obtains FDA Marketing Authorization for the First Prescription Digital Therapeutic to Treat Irritable Bowel Syndrome

Company announces industry veteran Steven Basta joining as CEO

Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition

Press Release Jan 10, 2020

Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition

Psychological-based digital therapy supported by strong clinical data from largest randomized clinical trial of its kind

Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition

Press Release Jan 10, 2020

Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition

Psychological-based digital therapy supported by strong clinical data from largest randomized clinical trial of its kind

First
Prev

1

Next
Last